Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

AstraZeneca Announced Evusheld Long-acting Antibody Combination Recommended for Approval in the EU for the Treatment of COVID-19

By Charles Gross
September 16, 4:52 AM
AstraZeneca's Evusheld (tixagevimab and cilgavimab, formerly AZD7442), a long-acting antibody combination, has been recommended for marketing authorisation in the European Union (EU) for the treatment of adults and adolescents (aged 12 years and older weighing at least 40 kg) with COVID-19 who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19.

AZN

Read More
3 minute read

US Stock Futures Mostly Flat Ahead Of Several Economic Reports; Adobe Earnings In Focus

By Lisa Levin
September 15, 5:05 AM
Pre-open movers U.S. stock futures traded mostly flat in early pre-market trade on Thursday after closing higher on Wednesday. The Nasdaq 100 index gained around 100 points in the previous session after U.S. producer prices dropped for a second consecutive month in August.

ADBE

Read More
1 minute read

Novartis Confirmed That It Has Been Contacted by the Swiss Competition Commission Regarding an Investigation Into the Assertion of a Patent Related to Dermatology Treatments

By Charles Gross
September 15, 4:56 AM
Novartis today confirms that it has been contacted by the Swiss Competition Commission (COMCO) which has initiated an investigation, in collaboration with the European Commission, into the assertion of a patent in the broader field of dermatology treatments. In connection with this investigation, COMCO representatives visited the company headquarters in Basel.

NVS